Title : Predictors of alpha-fetoprotein elevation in patients with chronic hepatitis C, but not hepatocellular carcinoma, and its normalization after pegylated interferon alfa 2a-ribavirin combination therapy.

Pub. Date : 2007 May

PMID : 17444854






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The change in AFP levels after treatment with pegylated interferon and ribavirin (Peg-IFN/RBV) combination therapy is still unknown. Ribavirin alpha fetoprotein Homo sapiens
2 The change in AFP levels after treatment with pegylated interferon and ribavirin (Peg-IFN/RBV) combination therapy is still unknown. Ribavirin alpha fetoprotein Homo sapiens
3 The aim of this study was to investigate the predictors of elevated serum AFP in patients with CHC, and its change after Peg-IFN/RBV therapy. Ribavirin alpha fetoprotein Homo sapiens
4 After Peg-IFN/RBV combination therapy, a higher platelet count and HCV viral eradication were determinants of normal AFP at EOF. Ribavirin alpha fetoprotein Homo sapiens